nDatalyze Corp. Expands AI Mental Health Tool

nDatalyze Corp (TSE:NDAT) has released an update.

nDatalyze Corp. has launched its AI-based depression assessment tool, Comprehensive Mental Condition Probability – Depression (CMCP-D), on Canada’s largest electronic medical record platforms, reaching over 60,000 physicians. The company is also rebranding its YMI system to CMCP-5, aiming to improve mental health diagnostics and expand its market presence. With interest from US-based EMRs, nDatalyze is poised for wider adoption of its mental health prediction systems.

For further insights into TSE:NDAT stock, check out TipRanks’ Stock Analysis page.